This Article Full Text Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Langford, E.J. Articles by Martin, J.F. Search for Related Content PubMed PubMed Citation Articles by Langford, E.J. Articles by Martin, J.F.

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1996;16:51-55.)
© 1996 American Heart Association, Inc.

Articles

Platelet Activation in Acute Myocardial Infarction and Unstable Angina Is Inhibited by Nitric Oxide Donors

E.J. Langford; R.J. Wainwright; J.F. Martin

From the Cardiology Department (E.J.L., R.J.W.), King's College Hospital, and the Department of Medicine (E.J.L., J.F.M.), King's College School of Medicine, London, England.

Correspondence to Prof J.F. Martin, Professor of Cardiovascular Science, Department of Medicine, King's College School of Medicine, Bessemer Rd, London SE5 9PJ, UK.

Abstract Platelet activation and thrombus formation within the coronary artery are major factors in acute myocardial infarction (AMI) and unstable angina (UA), and continuing platelet activation is associated with an adverse prognosis. We assessed platelet activation by using flow cytometry to measure platelet surface expression of P-selectin and glycoprotein IIb/IIIa in 20 patients with AMI and 20 with UA, all of whom were treated with aspirin. Platelet studies were repeated after the infusion of a nitric oxide donor (glyceryl trinitrate or S-nitrosoglutathione) that produced a fall in mean arterial pressure of no more than 10 mm Hg. P-selectin was expressed on 2.5% (range, 1.4% to 6.3%) of platelets from AMI and 2.3% (range, 1.6% to 3.3%) from UA subjects compared with 1.0% (range, 0.6% to 1.9%) of platelets from 20 control volunteers without angina (P<.001). Glycoprotein IIb/IIIa expression was 101.6±2.7 arbitrary units of relative fluorescence in AMI and 100.2±3.3 in UA compared with 87.8±2.5 in control subjects (P<.01). In both AMI and UA, S-nitrosoglutathione reduced P-selectin (P<.001) and glycoprotein IIb/IIIa (P<.05) expression, as did glyceryl trinitrate (P<.02 and P<.01, respectively). In 3 of 20 patients receiving glyceryl trinitrate the lowest dose was not tolerated due to headache or hypotension. These findings show that platelet activation persists in AMI and UA despite aspirin treatment and that this can be inhibited by using glyceryl trinitrate or S-nitrosoglutathione. S-nitrosoglutathione is better tolerated at the doses required.

Key Words: myocardial infarction • unstable angina • platelets • nitric oxide

This article has been cited by other articles:

				G. Vilahur, E. Segales, E. Salas, and L. Badimon Effects of a Novel Platelet Nitric Oxide Donor (LA816), Aspirin, Clopidogrel, and Combined Therapy in Inhibiting Flow- and Lesion-Dependent Thrombosis in the Porcine Ex Vivo Model Circulation, September 21, 2004; 110(12): 1686 - 1693. [Abstract] [Full Text] [PDF]

				Z. Kaposzta, A. Clifton, J. Molloy, J. F. Martin, and H. S. Markus S-Nitrosoglutathione Reduces Asymptomatic Embolization After Carotid Angioplasty Circulation, December 10, 2002; 106(24): 3057 - 3062. [Abstract] [Full Text] [PDF]

				M. Mirabet, D. Garcia-Dorado, J. Inserte, J. A. Barrabes, R.-M. Lidon, B. Soriano, M. Azevedo, F. Padilla, L. Agullo, M. Ruiz-Meana, et al. Platelets activated by transient coronary occlusion exacerbate ischemia-reperfusion injury in rat hearts Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H1134 - H1141. [Abstract] [Full Text] [PDF]

				L. Sanchez de Miguel, M. a M. Arriero, J. Farre, P. Jimenez, A. Garcia-Mendez, T. de Frutos, A. Jimenez, R. Garcia, F. Cabestrero, J. Gomez, et al. Nitric oxide production by neutrophils obtained from patients during acute coronary syndromes: expression of the nitric oxide synthase isoforms J. Am. Coll. Cardiol., March 6, 2002; 39(5): 818 - 825. [Abstract] [Full Text] [PDF]

				T O'malley, C.A Ludlam, R.A Riemermsa, and K.A.A Fox Early increase in levels of soluble inter-cellular adhesion molecule-1 (sICAM-1). Potential risk factor for the acute coronary syndromes Eur. Heart J., July 2, 2001; 22(14): 1226 - 1234. [Abstract] [PDF]

				Z. Kaposzta, P. A. Baskerville, D. Madge, S. Fraser, J. F. Martin, and H. S. Markus L-Arginine and S-Nitrosoglutathione Reduce Embolization in Humans Circulation, May 15, 2001; 103(19): 2371 - 2375. [Abstract] [Full Text] [PDF]

				T. V. Lewis, A. M. Dart, and J. P. F. Chin-Dusting Endothelium-dependent relaxation by acetylcholine is impaired in hypertriglyceridemic humans with normal levels of plasma LDL cholesterol J. Am. Coll. Cardiol., March 1, 1999; 33(3): 805 - 812. [Abstract] [Full Text] [PDF]

				J. H. Markovitz, L. Tolbert, and S. E. Winders Increased Serotonin Receptor Density and Platelet GPIIb/IIIa Activation Among Smokers Arterioscler Thromb Vasc Biol, March 1, 1999; 19(3): 762 - 766. [Abstract] [Full Text] [PDF]

				T. Minamino, M. Kitakaze, S. Sanada, H. Asanuama, T. Kurotobi, Y. Koretsune, M. Fukunami, T. Kuzuya, N. Hoki, and M. Hori Increased Expression of P-Selectin on Platelets Is a Risk Factor for Silent Cerebral Infarction in Patients With Atrial Fibrillation : Role of Nitric Oxide Circulation, October 27, 1998; 98(17): 1721 - 1727. [Abstract] [Full Text] [PDF]

				J. Molloy, J. F. Martin, P. A. Baskerville, S. C. A. Fraser, and H. S. Markus S-Nitrosoglutathione Reduces the Rate of Embolization in Humans Circulation, October 6, 1998; 98(14): 1372 - 1375. [Abstract] [Full Text] [PDF]

				K. A. Skinner, C. R. White, R. Patel, S. Tan, S. Barnes, M. Kirk, V. Darley-Usmar, and D. A. Parks Nitrosation of Uric Acid by Peroxynitrite. FORMATION OF A VASOACTIVE NITRIC OXIDE DONOR J. Biol. Chem., September 18, 1998; 273(38): 24491 - 24497. [Abstract] [Full Text] [PDF]

				E Salas, E J Langford, M T Marrinan, J F Martin, S Moncada, and A J de Belder S-Nitrosoglutathione inhibits platelet activation and deposition in coronary artery saphenous vein grafts in vitro and in vivo Heart, August 1, 1998; 80(2): 146 - 150. [Abstract] [Full Text]

				A. Gries, C. Bode, K. Peter, A. Herr, H. Bohrer, J. Motsch, and E. Martin Inhaled Nitric Oxide Inhibits Human Platelet Aggregation, P-Selectin Expression, and Fibrinogen Binding In Vitro and In Vivo Circulation, April 21, 1998; 97(15): 1481 - 1487. [Abstract] [Full Text] [PDF]

				P. Provost, J. Tremblay, and Y. Merhi The Antiadhesive and Antithrombotic Effects of the Nitric Oxide Donor SIN-1 Are Combined With a Decreased Vasoconstriction in a Porcine Model of Balloon Angioplasty Arterioscler Thromb Vasc Biol, September 1, 1997; 17(9): 1806 - 1812. [Abstract] [Full Text]

				Z. Kaposzta, J. F. Martin, and H. S. Markus Switching off Embolization From Symptomatic Carotid Plaque Using S-Nitrosoglutathione Circulation, March 26, 2002; 105(12): 1480 - 1484. [Abstract] [Full Text] [PDF]